Made primarily for advanced practice providers (APPs), the Director of Specialists for MASLD/MASH provides these professionals the ability to easily obtain contact information for liver specialists to assist with the... Read More
Author: MASLD
As conditions like obesity, type 2 diabetes, and cardiometabolic syndrome become more prevalent, advanced practice provider education on metabolic liver diseases is becoming ever more critical. Primary care and specialty... Read More
For APPs, the integration of primary care with liver health enhances early identification, streamlines structured risk assessments, and facilitates the organized management of liver health issues as a regular component... Read More
In today's transforming healthcare system, Advanced Practice Providers (APPs) engaging in multidisciplinary hepatology can assist with comprehensive and patient-centered management of liver-related disorders. With the growing metabolic liver disease burden,... Read More
The Role of Advanced Practice Providers in Managing Cardiometabolic Risk Factors helps in understanding the impact of metabolic liver disease and the long-term implications on cardiovascular and hepatic health. Advanced... Read More
The best practices for APPs involving the liver stiffness measurement (LSM) are important to ensure accurate evaluations of liver fibrosis, appropriate risk categorization, and the effective assimilation of elastography into... Read More
Today's clinicians must be able to comfortably perform and incorporate elements of non-invasive fibrosis assessment into daily practice. VCTE (Vibration Controlled Transient Elastography) or FibroScan is a primary assessment tool... Read More
Neoteric metabolic liver care incorporates non-invasive testing (NITs) in liver disease for APPs, allowing advanced practice providers to gauge the degree of liver fibrosis, refine their clinical approach, and circumvent... Read More
Advanced practice providers (APPs) involved in the care of patients with potential metabolic liver disease would greatly benefit from the APP Guide to FIB-4 Index Interpretation. The FIB-4 index is... Read More
Metabollic Liver Disease Advanced Practice Providers (APPs) need actionable strategies for the identification of patients at risk for the rapid progression of metabolic dysfunction—associated liver disease (MDCLD) to help manage... Read More